Read + Share
Niwa Y, Asano M, Nakagawa T, France D, et al. Antitumor Activity of Eribulin After Fulvestrant Plus CDK4/6 Inhibitor in Breast
Cancer Patient-derived Xenograft Models. Anticancer Res 2020;40:6699-6712.
PMID: 33288563
|
 |
|
Niwa Y, Asano M, Nakagawa T, France D, et al. Antitumor Activity of Eribulin After Fulvestrant Plus CDK4/6 Inhibitor in Breast
Cancer Patient-derived Xenograft Models. Anticancer Res 2020;40:6699-6712.
PMID: 33288563
|
|
|
|